Elizabeth H.z. Thompson, EVP, Research & Development at Horizon Therapeutics Public Ltd Co (HZNP), sold 82 shares at $85.01 ($7K) on 2022-07-07, disclosed to the SEC on 2022-07-11.
Scheduled sale ($7k) by EVP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HZNP | SELL | 2022-07-20 | $511K | — | Filing → |
| HZNP | SELL | 2022-04-20 | $1.9M | — | Filing → |
| HZNP | SELL | 2021-08-06 | $1.6M | — | Filing → |